DAIICHI SANKYO CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,578 JPY | +3.32% |
|
+2.46% | +44.06% |
| May. 28 | RevolKa Signs Master Service Agreement with Daiichi Sankyo | CI |
| May. 27 | AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 68.01B | ||||||
| 739B | ||||||
| 598B | ||||||
| 353B | ||||||
| 318B | ||||||
| 285B |
